Filing Details

Accession Number:
0001209191-18-054296
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-10-04 18:00:03
Reporting Period:
2018-10-02
Accepted Time:
2018-10-04 18:00:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
921299 Fibrogen Inc FGEN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1623238 B Thomas Neff C/O Fibrogen, Inc.
409 Illinois St.
San Francisco CA 94158
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-10-02 10,320 $3.60 2,727,574 No 4 M Direct
Common Stock Disposition 2018-10-02 8,998 $58.47 2,718,576 No 4 S Direct
Common Stock Disposition 2018-10-02 9,902 $59.16 2,708,674 No 4 S Direct
Common Stock Disposition 2018-10-02 718 $58.79 95,912 No 4 S Indirect By Family Partnership
Common Stock Disposition 2018-10-02 200 $59.37 95,712 No 4 S Indirect By Family Partnership
Common Stock Acquisiton 2018-10-03 10,319 $3.60 2,718,993 No 4 M Direct
Common Stock Disposition 2018-10-03 8,193 $58.82 2,710,800 No 4 S Direct
Common Stock Disposition 2018-10-03 10,707 $59.94 2,700,093 No 4 S Direct
Common Stock Disposition 2018-10-03 307 $58.68 95,405 No 4 S Indirect By Family Partnership
Common Stock Disposition 2018-10-03 611 $59.89 94,794 No 4 S Indirect By Family Partnership
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Indirect By Family Partnership
No 4 S Indirect By Family Partnership
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Indirect By Family Partnership
No 4 S Indirect By Family Partnership
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2018-10-02 10,320 $0.00 10,320 $3.60
Common Stock Stock Option (Right to Buy) Disposition 2018-10-03 10,319 $0.00 10,319 $3.60
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
196,061 2019-03-11 No 4 M Direct
185,742 2019-03-11 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 19,500 Indirect By Spouse
Common Stock 60,946 Indirect See footnote
Footnotes
  1. Shares sold pursuant to a 10b5-1 plan.
  2. The shares were sold at prices ranging from $57.955 to $58.95. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. The shares were sold at prices ranging from $58.96 to $59.61. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. The shares were sold at prices ranging from $58.22 to $59.15. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  5. The shares were sold at prices ranging from $59.23 to $59.50. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  6. The shares were sold at prices ranging from $58.33 to $59.30. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  7. The shares were sold at prices ranging from $59.33 to $60.29. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  8. The shares were sold at prices ranging from $58.62 to $58.73. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  9. The shares were sold at prices ranging from $59.73 to $60.19. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  10. The shares are held by BioGrowth Partners, LP. The reporting person is the sole general partner of BioGrowth Partners, LP and has sole voting and dispositive power over the shares held by BioGrowth Partners, LP.
  11. Fully vested.